Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease

Autor: Gareb, Bahez, Eissens, Anko C., Kosterink, Jos G.W., Frijlink, Hendrik W.
Zdroj: In European Journal of Pharmaceutics and Biopharmaceutics June 2016 103:32-42
Databáze: ScienceDirect